Stock NRSN NEUROSENSE THERAPEUTICS LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart NeuroSense Therapeutics Ltd.

Equities

NRSN

IL0011809592

Market Closed - Nasdaq
Other stock markets
 21:00:00 17/05/2024 BST 		5-day change 1st Jan Change
1.21 USD -0.82% Intraday chart for NeuroSense Therapeutics Ltd. +2.54% +54.14%
05-14 NeuroSense Partners with PhaseV for ALS Treatment Trial -- Shares Up MT
05-07 NeuroSense Announces New Positive Data Analysis from PARADIGM Clinical Trial Demonstrating Statistically Significant Slowing of Disease Progression in High-Risk ALS Patients CI
bb2435a495de6170b28f6bc7.d1Zdd2-tbX85S5s-Tle88a1Yp49qnRXoEf2tm4cTYIQ.DmM6IBefJj5sOKwLPmbjtMgd0f8w3mC7co7ny_ArI7UmNAkxAZoYCWxz8A~f8805286d4673cf67950ee9d18215a04
  1. Stock Market
  2. Equities
  3. NRSN Stock
  4. Charts NeuroSense Therapeutics Ltd.
  5. News Chart